Ascendis Pharma A/S
F:A71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
A
|
Adaro Energy Indonesia TBK PT
SWB:A64
|
ID |
|
L
|
London Stock Exchange Group PLC
XMUN:LS4C
|
UK |
|
E
|
Eltel AB
SWB:E5E
|
SE |
|
Loop Industries Inc
NASDAQ:LOOP
|
CA |
|
T
|
Thales SA
DUS:CSF
|
FR |
|
O
|
Oneflow AB
STO:ONEF
|
SE |
Wall St Price Targets
A71 Price Targets Summary
Ascendis Pharma A/S
According to Wall Street analysts, the average 1-year price target for A71 is 227.1 EUR with a low forecast of 192.16 EUR and a high forecast of 277.03 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A71's stock price target?
Price Target
227.1
EUR
According to Wall Street analysts, the average 1-year price target for A71 is 227.1 EUR with a low forecast of 192.16 EUR and a high forecast of 277.03 EUR.
What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
24%
Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 24%.
What is the Gross Profit forecast for Ascendis Pharma A/S?
Projected CAGR
25%
The compound annual growth rate for Gross Profit over the next 8 years is 25%.
